PMID- 33447423 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220419 IS - 2072-1439 (Print) IS - 2077-6624 (Electronic) IS - 2072-1439 (Linking) VI - 12 IP - 12 DP - 2020 Dec TI - Effects of enteral nutrition support combined with enhanced recovery after surgery on the nutritional status, immune function, and prognosis of patients with esophageal cancer after Ivor-Lewis operation. PG - 7337-7345 LID - 10.21037/jtd-20-3410 [doi] AB - BACKGROUND: Esophageal cancer (EC) with a high incidence of malnutrition is a highly malignant digestive tract tumor. We investigated the effect of enteral nutrition (EN) support combined with enhanced recovery after surgery (ERAS) on the nutritional status, immune function, and prognosis of patients with EC after Ivor-Lewis operation. METHODS: One hundred patients were randomly divided into the observation group (n=42) and the control group (n=58). The patients in observation group were treated with EN combined with ERAS intervention after Ivor-Lewis operation, and the patients in control group were treated with conventional postoperative EN intervention. The situation of operation, nutritional status, immune function recovery and prognosis between the two groups were compared. RESULTS: There was no statistically significant difference in operation time or intraoperative blood loss between the two groups (P>0.05). The chest tube removal time and oral feeding time of the observation group after operation were shorter than those of the control group (P<0.05). After intervention, serum albumin (ALB), transferrin (TF), pre-albumin (PA) and hemoglobin (Hb) levels in both groups were significantly decreased. These indexes were significantly higher in the observation group than in the control group (P<0.05). There were no significant changes in the levels of immunoglobulin (Ig) A, IgG, and IgM, or the numbers of CD3(+), CD4(+) and CD4(+)/CD8(+) T cells in the observation group before and after intervention (P>0.05); however those indexes were significantly decreased in the control group after the intervention (P<0.05). Interestingly, the levels of IgA, IgM, IgG, CD3(+) T cells, CD4(+) T cells and CD4(+)/CD8(+) T cells in the observation group were significantly higher than those in the control group after intervention (P<0.05). The incidence of pulmonary infection in the observation group was significantly lower than that in the control group. The postoperative exhaust time, postoperative defecation time and postoperative hospital stay were shorter in the observation group than in the control group (P<0.05). There was no significant difference in hospitalization cost between the two groups (P>0.05). CONCLUSIONS: EN combined with ERAS was more beneficial to the improvement of nutritional status and immune function recovery of patients with EC after Ivor-Lewis operation. It also shortened the length of hospital stay. CI - 2020 Journal of Thoracic Disease. All rights reserved. FAU - Ding, Haibing AU - Ding H AD - Department of Thoracic Surgery, the First Affiliated Hospital of Soochow University, Suzhou, China. AD - Department of Thoracic Surgery, Second People's Hospital of Taizhou City, Taizhou, China. FAU - Xu, Jin AU - Xu J AD - Department of Gastroenterology, Geriatric Hospital of Nanjing Medical University, Nanjing, China. FAU - You, Jijun AU - You J AD - Department of Thoracic Surgery, Second People's Hospital of Taizhou City, Taizhou, China. FAU - Qin, Haifeng AU - Qin H AD - Department of Thoracic Surgery, Second People's Hospital of Taizhou City, Taizhou, China. FAU - Ma, Haitao AU - Ma H AD - Department of Thoracic Surgery, the First Affiliated Hospital of Soochow University, Suzhou, China. LA - eng PT - Journal Article PL - China TA - J Thorac Dis JT - Journal of thoracic disease JID - 101533916 PMC - PMC7797812 OTO - NOTNLM OT - Enteral nutrition support OT - Ivor-Lewis operation OT - enhanced recovery after surgery (ERAS) OT - esophageal cancer (EC) OT - nutritional status COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-3410). The authors have no conflicts of interest to declare. EDAT- 2021/01/16 06:00 MHDA- 2021/01/16 06:01 PMCR- 2020/12/01 CRDT- 2021/01/15 06:01 PHST- 2021/01/15 06:01 [entrez] PHST- 2021/01/16 06:00 [pubmed] PHST- 2021/01/16 06:01 [medline] PHST- 2020/12/01 00:00 [pmc-release] AID - jtd-12-12-7337 [pii] AID - 10.21037/jtd-20-3410 [doi] PST - ppublish SO - J Thorac Dis. 2020 Dec;12(12):7337-7345. doi: 10.21037/jtd-20-3410.